Lv1
100 积分 2021-01-24 加入
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
10天前
已完结
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
13天前
已完结
Delivery of Engineered Primary Tumor-Derived Exosomes Effectively Suppressed the Colorectal Cancer Chemoresistance and Liver Metastasis
13天前
已完结
Nanoparticles modified by triple single chain antibodies for MRI examination and targeted therapy in pancreatic cancer
13天前
已完结
Targeting neuropilin-1 abolishes anti-PD-1-upregulated regulatory T cells and synergizes with 4-1BB agonist for liver cancer treatment
16天前
已完结
Hepatic inflammatory responses in liver fibrosis
24天前
已完结
The fibroinflammatory response in cancer
25天前
已完结
A mechanism for hypoxia-induced inflammatory cell death in cancer
1个月前
已完结
PPAR mediates intestinal stem cell tumorigenesis
1个月前
已完结
PPAR control of metabolism and cardiovascular functions
1个月前
已完结
皖公网安备34019202002308
